Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

Completed · Not applicable

Conditions studied: HIV Infections

In brief

The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Health-ITUEM), the proposed project will refine and test a next-generation diagnostic intervention delivered on a mobile platform to improve HIV testing and linkage-to-care outcomes among youth living with and at-risk for HIV. Given the pervasiveness, low cost, and convenience of mobile technology, the investigators hope that the App can help achieve the goals of the National HIV/AIDS Strategy in the US by increasing the number of persons living with HIV who know their serostatus, decreasing HIV-related disparities, and ultimately reducing the risk of HIV transmission and acquisition.

Key facts

Study ID

NCT03803683

Run by

Rebecca Schnall, RN, MPH, PhD

People needed

525

Starts

2020-01-21

Expected to finish

2023-10-02

Last updated by the study team

2024-11-26

Who can join

Age: 18 and older, up to 29. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Birth sex male of any current gender identification;
• Understand and read English
• Substantial risk for acquiring HIV infection per CDC guidance (e.g.,YMSM or YTGW and recent anal sex with men)
• Smartphone ownership
• Self-report being HIV-negative or unknown status
• Understand the limitations of the OraQuick test and the mLab App
• Not having been tested for HIV in the past 6 months (e.g., therefore being somewhat outside of the current CDC testing recommendations for high-risk populations)
• Not currently taking PrEP
• Receive a non-reactive result on the rapid HIV test at the Baseline visit

You may not qualify if…

• Persons who have a known diagnosis of HIV
• Persons for whom the investigators determine that participation may be detrimental to the participant or to the study (e.g., severe cognitive deficit).

Where it is running

• Lurie Children's Hospital — Chicago, Illinois, United States
• Columbia University School of Nursing — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.